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Abstract
Cystic fibrosis airway epithelia exhibit a spectrum of ion
transport properties that differ from normal, including not
only defective cAMP-mediated Cl- secretion, but also in-
creased Na+ absorption and increased Ca2"-mediated Cl-
secretion. In the present study, we examined whether adeno-
virus-mediated (Ad5) transduction of CFTR can correct all
of these CF ion transport abnormalities. Polarized primary
cultures of human CF and normal nasal epithelial cells were
infected with Ad5-CBCFTR at an moi (104) which trans-
duced virtually all cells or Ad5-CMV lacZ as a control. Con-
sistent with previous reports, Ad5-CBCFTR, but not Ad5-
CMV lacZ, corrected defective CF cAMP-mediated Cl - se-
cretion. Basal Na + transport rates (basal I,q) in CF airway
epithelial sheets (-78.5±9.8 puA/cm2) were reduced to levels
measured in normal epithelial sheets (-30.0±2.0 pAA/cm2)
by Ad5-CBCFTR (-36.9±4.8 1uA/cm2), but not Ad5-
CMV lacZ ( -65.8±6.1 IAA/cm2). Surprisingly, a signfficant
reduction in AIq in response to ionomycin, a measure of
Ca2+-mediated Cl- secretion, was observed in CFTR-ex-
pressing (corrected) CF epithelial sheets (-6.9±11.8 ,uA/
cm2) when compared to uninfected CF epithelial sheets
(-76.2±15.1 puA/cm2). Dose response effects of AdS-
CBCFTR on basal Na+ transport rates and Ca2+-mediated
Cl- secretion suggest that the mechanism of regulation of
these two ion transport functions by CFTR may be different.
In conclusion, efficient transduction of CFTR corrects hy-
perabsorption of Na + in primary CF airway epithelial cells
and restores Ca2+-mediated Cl- secretion to levels observed
in normal airway epithelial cells. Moreover, assessment of
these ion transport abnormalities may represent important
endpoints for testing the efficacy of gene therapy for cystic
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Introduction
Cystic fibrosis (CF),' the most common potentially lethal ge-
netic disease in Caucasians, is caused by abnormal electrolyte
transport in airway, sweat ductal, intestinal and pancreatic duc-
tal epithelia (1, 2). The CF gene product, the cystic fibrosis
transmembrane conductance regulator (CFTR), has been shown
to be a cAMP-activated Cl- channel (3-5) and more recently
to regulate the activity of other ion channels (6, 7). Comple-
mentation of the CF Cl - permeability defect in vitro using
adenovirus, retrovirus, vaccinia virus, and adeno-associated vi-
rus vectors strongly supports the notion that gene therapy for
cystic fibrosis is feasible (7-11). These studies have also
spurred current clinical safety and efficacy gene transfer trials
in the nasal cavity and lower airways of CF patients (12, 13).
All of the efforts in gene transfer for CF thus far have
focused on correction of abnormal cAMP-mediated regulation
of Cl- transport function (12). However, CF airway epithelia
are also characterized by raised Na+ transport (14, 15) and a
raised alternative Ca2+-regulated Cl- secretory path (16-18).
It has been speculated that abnormal Na+ transport is central
to the pathogenesis of CF airways disease (19), whereas the
alternative Ca2+-mediated Cl - secretory path may be protective
(18). Although not proven, both of these defects appear to
reflect abnormal upregulation of channel expression/activity
consequent to mutated CFTR (15, 16, 18).
In the present study, we tested whether introduction of wild-
type CFTR into CF airway epithelia normalizes raised Na+
absorption and raised Ca2+-mediated Cl - secretion in CF air-
way epithelia and consequently, whether these defects are po-
tentially important endpoints of the efficacy of gene therapy.
1. Abbreviations used in this paper: A, change; AdS, adenovirus sero-
type 5; AdS-CBCFTR, adenovirus serotype 5-based vector in which a
CMV enhancer and ,3-actin promoter drive transcription of CFTR; AdS-
CMV lacZ, AdS-based vector in which a CMV enhancer/promoter
drives transcription of the /3-galactosidase gene; CF, cystic fibrosis;
CFTR, cystic fibrosis transmembrane conductance regulator; Cla, alter-
native chloride conductance; 1cq. equivalent short circuit current; LacZ,
/3-galatosidase; R, transepithelial resistance; Vt, transepithelial potential
difference.
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Methods
Cell culture. CF and normal nasal epithelial cells, isolated from surgical
specimens by enzymatic digestion, were cultured as previously de-
scribed (20). Cells were plated on permeable collagen substrates (sur-
face area = 0.16 cm2) at supraconfluent densities, maintained in serum-
free medium (Ham's F12) supplemented with seven growth factors
(20) until day 4 in culture, then switched to 50% Swiss 3T3-conditioned
Dulbecco's modified Eagles medium with 4500 g/L glucose plus 2%
bovine calf serum diluted in serum-free medium. In dose effect relation-
ship experiments, cells were grown on collagen substrates (surface area
= 0.071 cm2) under air liquid interface conditions (21) in the absence
of cholera toxin.
Adenoviruses. Adenovirus vectors used in this study are replication
defective viruses based on the human adenovirus serotype 5 (AdS).
Their construction and the preparation of viral stocks was as previously
described (22). In this study, Ad5-CMV lacZ and Ad5-CBCFTR with
titers of up to 1011 pfu/ml were utilized.
Viral infections. Primary CF airway epithelial sheets were infected
at confluence (culture day 3) overnight (-18 h) with 30 Ml of either
Ad5-CBCFTR or Ad5-CMV lacZ virus-containing medium at a multi-
plicity of infection (moi) of 104, or sham infected. Cells were then
washed and maintained in 50% Swiss 3T3-conditioned medium for three
additional days after infection. In the dose effect relationship experi-
ments, cells were infected with 10 ,l of AdS-CBCFTR (in view of the
smaller surface area) at the following mois: 0, 10-', 100, 10', 102,
103, and I04.
Bioelectric measurements. The transepithelial potential differences
(V,) and resistances (R,) of all cultures were monitored (EVOM; World
Precision Instruments, Inc., Sarasota, Florida) over days 4-6 in culture
and the basal equivalent short circuit current (Ieq) calculated. To charac-
terize the Cl- transport function, cultures were mounted in a modified
Ussing chamber interfaced to a current-voltage clamp (VCC600, Revi-
sion E; Physiologic Instruments, San Diego, CA) and superfused with
Krebs-Ringer Bicarbonate solution, pH 7.4 at 37°C aerated with 95%
02-5% CO2- The sequential bioelectric responses to i0' M amiloride
added to the luminal bath, luminal Cl- replacement with 0 mM Cl-
containing Ringer (gluconate substituted for chloride), 10M4M forskolin,
and 5 MM ionomycin were measured.
Western blots. Western Blots were performed as previously de-
scribed (23). Samples were harvested by direct application of 35 Ml
urea buffer (67.5 mM Tris, pH 6.8; 7 M urea; 160 mM Dithiothreitol;
2% sodium dodecyl sulfate; 0.001I% bromophenol blue) to the collagen
substrate and stored at -70°C. Equal amounts of protein (50 Mg/well)
were loaded onto a 4-15% polyacrylamide gel and electrophoresis was
performed at 1IOV for 60 min. Blotting onto polyvinylidene difluoride
(PVDF) membranes (0.2 Am pore size; Bio Rad Labs., Hercules, CA)
and immunodetection with anti-CFTR COOH terminus antibody was
performed as previously described. T84 cell membranes were used as
a marker of fully glycosylated CFTR.
Immunohistochemistry. Epithelial sheets on collagen membrane sup-
ports were detached from their polycarbonate supports using a scapel,
embedded in OCT compound (Miles, Inc., West Haven, CT), and frozen
at -70°C. Frozen sections (8-Mm thickness) were cut on a Reichert
Cryo-cut 1800 and stained for CFTR expression using a rabbit poly-
clonal anti-COOH terminus antibody (a1468, obtained from Dr. Jona-
than Cohn, Duke University, Durham, NC) and a FITC-conjugated
secondary antibody for immunofluorescent detection as previously de-
scribed (24).
Statistics. All values are recorded as means±SE. Determination of
statistical significance was performed using the student's t test. Signifi-
cance was defined as p < 0.05. An analysis of variance (ANOVA) was
used to detect statistical significance in the dose effect relationship
experiments.
Results
Characterization ofCFTR protein expression. As shown in Fig.
1 A, Western blot analysis revealed that CFTR protein was
expressed in high levels in CF epithelial sheets infected with
Ad5-CBCFTR, while CFTR was barely detectable in uninfected
sheets or 6-galactosidase (LacZ)-expressing epithelial sheets.
Note that two bands were seen in whole cell lysates of CF cells
expressing transduced CFTR: the fully glycosylated or mature
form corresponding to a band at 180 kD and the core glycosyl-
ated protein at 140 kD. T84 cell membranes, used as a marker
ofCFTR, exhibited a majorband at 180 kD, which was expected
since the fully glycosylated form would be primarily expressed
in the membrane. CFTR protein could not be clearly detected
in cultured primary normal airway epithelial cells (Fig. 1 A, lane
6), although these cells exhibit normal Cl - transport function.
Shown in Fig. 1 B is immunohistochemistry for CFTR in cor-
rected (Ad5-CBCFTR-infected) CF epithelial sheets. Note that
staining is present in all cells facing the lumen in corrected
sheets. Moreover, both apical and cytoplasmic staining patterns
are present consistent with high level expression of CFTR. In
contrast, no immunohistochemical staining for CFTR protein
is detected in the AdS-CBCFTR-infected CF epithelial sheets
stained with secondary antibody alone (Fig. 1 C).
Characterization ofbasal Na + transport rates. Previous ra-
dioisotopic flux data have shown that basal I,q equals net Na+
absorption in cultured human airway epithelia (15). Because
basal Ieq generally peaks on culture day 6, we monitored the
basal Ieq in primary CF and normal airway cells daily from days
4-6 in culture. The expected pattern of a two- to threefold
greater Iq in uninfected CF cells as compared to uninfected
normal cells was observed on days 5 and 6 in culture (Fig. 2
A). In contrast, the basal 'eq in corrected CF epithelial sheets
was similar to the basal 'eq measured in the normal epithelial
sheets, consistent with correction of Na+ transport (Fig. 2 B).
An approximately twofold reduction in the mean basal Iq in
CFTR-expressing CF epithelial sheets (corrected cells) was
measured three days after infection (-36.9±4.8 MA/cm2; Fig.
2 B) when compared to uninfected (-78.5±9.8 ,A/cm2; Fig.
2 A) or LacZ-expressing CF cells (-65.8±6.1 MA/cm2; Fig. 2
C). The expression of LacZ or CFTR by AdS vectors did not
alter the rate of Na+ transport in normal airway epithelial cul-
tures (compare Fig. 2, A-C).
Characterization of basal Cl - transport function. We stud-
ied a series of CF and normal epithelial sheets in Ussing cham-
bers to characterize their Cl - secretory capacity. Shown in Fig.
3 A is the percent inhibition of Ieq by the Na+ channel blocker,
amiloride. Amiloride in airway epithelia both abolishes Na+
transport and induces a driving force for Cl- secretion (15).
Thus, the percent inhibition of Iq by amiloride reflects in part,
the ability of the apical membrane to conduct transepithelial
Cl - ion flows. Amiloride inhibited basal Iq in uninfected and
LacZ-expressing CF cells 90%, consistent with the absence
of a significant basal Cl- conductance. In contrast, a signifi-
cantly lower percent inhibition of Iq occurred post-amiloride
in CFTR-expressing CF cells (61.8+4.8%), consistent, in part,
with the expression of a basal Cl- conductance.
The change in transepithelial potential difference with re-
placement of luminal Cl- by gluconate (AV,c,-F,e) reflects in
part, the Cl- permselectivity of the apical membrane. The small
change (A) VtClFRe measured in uninfected (-1.7±2.0 mV)
and LacZ-expressing (-4.3±1.6 mV) CF cells is consistent
with the absence of a significant apical membrane Cl- conduc-
tance (Fig. 3 B). A significantly more negative AVt Cl-Free was
detected in CFTR-expressing CF cells (-36.2±3.6 mV), sug-
1378 Johnson et al.
A 180 kd-*
1 2 34 56
B
C
BFigure 1. Characterization of CFTR expression in CF and normal epithelial sheets. (A) Western blot of CF airway cells from epithelial sheets
infected with either Ad5-CBCFTR or Ad5-CMV lacZ using an anti-CFTR COOH terminus antibody. UNIF represents uninfected CF cells. LacZ
represents CF epithelial cells three days after infection with Ad5-CMV lacZ. CFTR represents CF cells infected with Ad5-CBCFTR three days after
infection. Lanes are as follows: 1, T84; 2, UNIF; 3, LacZ; 4, CFTR; and 5, LacZ. Shown in lane 6 are uninfected cultured primary normal airway
epithelial cells. B shows immunohistochemical detection of CFTR using an anti-COOH terminus polyclonal antibody (a1468) and a fluorescein-
conjugated secondary antibody in an Ad5-CBCFTR-infected (corrected) CF epithelial sheet. The arrow points out a cell on the lumen expressing
CFTR identified by the green fluorescent staining. Shown in C is a corrected CF epithelial sheet stained with secondary, but no primary antibody.
Note the absence of CFTR staining on cells facing the lumen depicted by the arrow.
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gesting the induction of a large apical membrane permeability
in the corrected cells (Fig. 3 B).
Characterization ofcAMP-mediated Cl - transportfunction.
The change in short circuit current induced by the cAMP-medi-











Figure 3. Characterization of
basal and cAMP-mediated Cl-
transport function in CF airway
epithelial sheets. A displays the
percent inhibition of leq by ami-
loride. B shows the change in
transepithelial voltage with lu-
minal chloride substitution
(AVtCl-Free). Shown in C is the
change in 'eq in response to the
cAMP-mediated agonist, for-
skolin (lMeq Forskolin). The re-
sponses displayed were sequen-
tial, ie., amiloride, added to the
luminal bath, was followed by
luminal Cl - substitution (still in
the presence of amiloride), and
the subsequent addition of for-
skolin. * indicates significantly
different from uninfected cells.
UNIF, n = 5; LacZ, n = 9;
















0 _ Figure 4. Characterization of
NL CF Ca-2-mediated C1 transport
function in normal and CF air-
CFTR way epithelial sheets. Shown in
A are data for uninfected epithe-
o0 lial sheets (NL, n = 8; CF, n
Fs = 16). Shown in B are data for
0o epithelial sheets infected with
Ad5-CBCFTR (NL, n = 6; CF,
!5 n = 17). An * indicates signifi-To cantly different from normal
cells. t indicates significantly
NL CF different from uninfected cells.
tion of the apical membrane Cl- conductance. No significant
change in AIeq Forskolin was detected in uninfected ( -2.0+1.0 HA/
cm2) and LacZ-expressing (-7.6+2.0 MAA/cm2) CF epithelial
sheets. In contrast, a significantly greater AIeq Forskolin was
detected in the CFTR-expressing CF cells (-22.6+6.5 ,uA/
cm2), consistent with the induction of normally functioning
CFTR Cl- channels in the apical membrane (Fig. 3 C).
Ca2"-mediated Cl - secretion. A consistently greater change
in leq in response to Ca2+-mediated agonists has been observed
in CF epithelia compared to normal airway epithelia both in
vitro and in vivo (16, 17). Uninfected CF epithelial sheets
responded to ionomycin (5 ,uM) with a significantly greater
AIeq ionomycin than that measured in uninfected normal epithelial
sheets (Fig. 4 A). Surprisingly, expression of CFTR was associ-
ated with a significantly smaller AIeq ionomycin in corrected CF
epithelial sheets (-6.9±11.8 ,uAA/cm2) than that observed in
uninfected (-76.2±15.1 ,uA/cm2) CF epithelial sheets (Fig. 4,
A and B).
Dose effect relationship ofAdS-CBCFTR on ion transport
function. To begin to address the issue of mechanism of CFTR
regulation of Na+ transport and Ca2+-mediated Cl - secretion
by CFTR, we tested the effect of increasing dose or moi of
Ad5-CBCFTR on ion transport function in primary CF airway
epithelial cells. As shown in Fig. 5 A, no dose effect relationship
of Ad5-CBCFTR on basal Na+ transport rates (basal Ieq) could
be demonstrated. A twofold reduction in the basal leq was de-
tected at the highest moi of 104, although not statistically sig-
nificant by an ANOVA. However, the reduction in 'eq is consis-
tent with data presented in Fig. 2. In contrast, a statistically
significant dose-related decline in Ca2+-mediated Cl- secretory
current was detected with increasing moi of vector (Fig. 5 B).
Discussion
In the present study, we utilized adenovirus-mediated transduc-
tion of CFTR into CF airway epithelia to examine the effects
of CFTR on the Na+ absorptive pathway. We used a high moi
in this study to ensure maximal gene transfer efficiency, because
it was designed to test the concept that Na+ transport is a
correctable defect. The Western blot data (Fig. 1 A) presented
indicate a high level expression of CFTR in corrected, but not
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Figure 5. Dose Response of Ad5-CBCFTR on Na+ transport and Ca' -
mediated Cl - secretion in primary CF epithelia. Shown in A is the effect
of increasing doses (moi) on basal Ie, (Na+ transport). B shows the
effect of increasing moi on the change in current with ionomycin. n
= 9-12 epithelial cell cultures for each dose of vector.
uninfected or LacZ-expressing CF tissues. Immunohistochemis-
try for CFTR (Fig. 1 B) not only confirms the western blot
data, but also demonstrates that every cell facing the airway
lumen has been transduced in Ad5-CBCFTR-infected CF epi-
thelial sheets. Consistent with efficient transduction of CFTR,
indices of Cl- transport in CFTR-expressing tissues demon-
strated restoration of basal and cAMP-mediated Cl- secretion
when compared to uninfected or LacZ-expressing CF epithelial
sheets as reported by others (Fig. 3).
Using this strategy, we found that the CF Na+ transport
defect was corrected by introduction of wild-type CFTR. The
rate of Na+ transport (basal Ieq) was downregulated in CFTR-
expressing CF epithelial sheets (Fig. 2 B) to rates similar to
those of normal epithelial sheets. This effect appears to be spe-
cific to CFTR transduction and not vector exposure, because
Ad5-CMV lacZ infection had no significant effect on basal Ieq
(Fig. 2 C). Moreover, additional CFTR does not further down-
regulate Na+ transport in normal cells.
Previous in vitro and in vivo studies suggest that the
nonCFTR-mediated or alternative apical membrane Cl- con-
ductance (Cla) is increased in human CF airway epithelia when
compared to normal airway epithelia ( 16, 17). Studies in the
CF( - /-) mouse model demonstrated that Ca2 -mediated Cl -
secretion occurs through this alternative pathway and that the
Cla may be protective ( 18). In the present study, we found that
adenovirus-mediated transduction of CFTR resulted in func-
tional reduction ofCa> -mediated Cl - secretion in CF epithelial
sheets. This decrease in the Ca2 -mediated Cl- secretory re-
sponse in corrected tissues is consistent with restoration of Cla
pathway to normal levels.
Because the Na+ channel subunits have only recently been
cloned (25, 26) and Cla has not yet been cloned, it is difficult
to explain the mechanism by which CFTR exerts effects on
both Na+ transport and Cl, activity. To gain some insight into
potential mechanisms, the dose effect relationships between
vector moi and correction of Na + transport rates and Cla activity
were examined (Fig. 5). Na+ transport was not corrected until
high mois were employed, consistent with a requirement for
transduction of most cells in the monolayer (Fig. 1). This rela-
tionship suggests that correction of Na+ transport is a linear
function of CFTR transfer efficiency, and that little amplifica-
tion of correction is achieved, contrasting with studies in which
correction of as few as 6-10% of cells restored cAMP-mediated
Cl- transport to normal (27). The simplest hypothesis is that
direct interactions of CFTR protein and Na+ channel protein
account for this phenomenon, and this interaction must occur
in each transduced cell to normalize Na+ channel function. This
hypothesis is consistent with microelectrode and patch clamp
data (15, 28), which indicate that the abnormally raised CF
Na+ transport rates reflect upregulation of apical membrane
Na+ entry, as manifested by an increase in Na+ channel open
probability (PO). The ability of CFTR to regulate the functional
activity of an independent ion channel, the outwardly rectifying
chloride channel (ORCC), provides support for such a mecha-
nism (6, 7).
In contrast, Cla function was reduced at low mois, implying
that amplification of low efficiency CFTR transduction oc-
curred. However, the decrease in Ca2+-mediated Cl- secretion
(Cla) with increasing moi, as compared to an increase in cAMP-
mediated Cl- secretion (29), indicates that Cl- movement
through gap junctions (27) is not the mechanism responsible
for the amplification of the Cla response. We speculate that
this observation might be explained by an inverse relationship
between expression of CFTR and Cla, as has been reported for
CFTR and multidrug resistance (MDR) (30), or that other
unknown factors regulating expression of Cla may be involved.
In summary, efficient expression of wild-type CFTR by
AdS-mediated gene transfer reduces raised Na+ transport rates
to levels observed in normal epithelial cell sheets. Hence, CFTR
function is closely linked to regulation of Na+ transport permit-
ting, in theory, correction of both defective Cl- secretion and
Na+ hyperabsorption by gene therapy. Correction of defective
cAMP-mediated Cl - transport and Na+ hyperabsorption in this
study was also associated with a reversal of the reciprocal rela-
tionship between functioning CFTR and Ca2 -mediated Cl -
secretion. Because defects other than cAMP-mediated Cl-
transport may be important in pathogenesis of airways disease,
these results suggest that future gene therapy efforts should
develop protocols that measure all aspects of CF dysfunction
and correction.
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